Elixher Uncategorized Hardy sees fertile ground in D.C. for Biomarin’s rare disease strategy – BioCentury

Hardy sees fertile ground in D.C. for Biomarin’s rare disease strategy – BioCentury

With its first acquisition in over 10 years, Biomarin’s strengthening balance sheet and renewed corporate strategy mean the genetically defined …

Related Post